A sprinkle formulation of lopinavir/ritonavir versus an oral solution formulation (Kaletra) in volunteers

Trial Profile

A sprinkle formulation of lopinavir/ritonavir versus an oral solution formulation (Kaletra) in volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 15 Mar 2012

At a glance

  • Drugs Lopinavir/ritonavir (Primary) ; Lopinavir
  • Indications HIV infections
  • Focus Pharmacokinetics
  • Sponsors Cipla
  • Most Recent Events

    • 15 Mar 2012 New trial record
    • 08 Mar 2012 Results presented at the 19th Conference on Retroviruses and Opportunistic Infections.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top